Leading pharma-packaging firm, Kaisha Packaging, has successfully delivered over 2 billion doses worth of flip-top aluminium seals used for packaging Covid vaccines. The seal is used as a closure for injection vials during the vaccination drive and is an essential part of the vaccine package that ensures tamper-proof delivery.
Kaisha Packaging has been the biggest supplier for these seals to all the vaccines available in the Indian market and abroad. The company managed to arrange and stock an extremely large volume of raw material to ensure a consistent supply of vaccines and plug any shortages or gaps. Kaisha Packaging also expanded its capacity by over 450 million pieces to reach the overall capacity of 1.2 billion pieces per annum over the past year.
Kaisha Packaging on supporting India’s vaccine drive
Rishad Dadachanji, director, Kaisha Group of companies, shared, “This is a testimonial of our commitment to support India’s vaccine drive and developers with the best packaging solutions. As a pharma allied sector company, we have worked hard to ensure no gaps remain in our supply chain to ensure a consistent supply of vaccine seals. We are proud to have provided seals for over 2 billion vaccine doses so far. Under the current circumstances of ambiguity around the Covid-19 pandemic, Kaisha is well-prepared to rise up to any supply challenges.”
Kaisha Packaging was established as a premium manufacturer of pharmaceutical closure systems for vials and specialty plastics for pharmaceutical use in 2003.
The company is part of the larger (Dadachanji Group), headquartered in Mumbai, India. It is a diversified group with business interests, including pharmaceuticals and biotechnology, primary and secondary packaging, medical devices, machine building, automation, and robotics. The group previously also owned a part of the Indo-German Venture Schott-Kaisha, the largest vaccine vial supplier in the country.
